"Combinant" is not a widely recognized term in the English language. However, based on context and research, it is possible that the term refers to "Combinant" or "Combinant Inc.", a Delaware-based biotechnology company that specializes in developing and manufacturing recombinant protein-based products for medical and industrial use.
The company was founded in 1986 and has since developed several commercial products, including alpha-galactosidase for the treatment of Fabry disease, Myozyme for the treatment of Pompe disease, and Recombumin, a recombinant albumin for use in various medical applications. Combinant also provides contract manufacturing services for clients looking to produce recombinant proteins.
Combinant is committed to developing innovative and cost-effective solutions to address unmet medical needs and improve global health. They use advanced protein engineering and manufacturing technologies to develop products that are safe, effective, and affordable. Combinant is constantly evolving and investing in research and development to maintain its position as a leader in the biotechnology industry.
Ne Demek sitesindeki bilgiler kullanıcılar vasıtasıyla veya otomatik oluşturulmuştur. Buradaki bilgilerin doğru olduğu garanti edilmez. Düzeltilmesi gereken bilgi olduğunu düşünüyorsanız bizimle iletişime geçiniz. Her türlü görüş, destek ve önerileriniz için iletisim@nedemek.page